文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在心血管-肾脏-代谢综合征 0-3 期人群中,甘油三酯-葡萄糖-体重指数与未来心血管疾病风险的关系:一项全国性前瞻性队列研究。

Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study.

机构信息

Shanghai Heart Failure Research Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Cardiovasc Diabetol. 2024 Aug 7;23(1):292. doi: 10.1186/s12933-024-02352-6.


DOI:10.1186/s12933-024-02352-6
PMID:39113004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308445/
Abstract

BACKGROUND: The American Heart Association (AHA) has recently introduced the concept of Cardiovascular-Kidney-Metabolic (CKM) syndrome, which is the result of an increasing emphasis on the interplay of metabolic, renal and cardiovascular diseases (CVD). Furthermore, there is substantial evidence of a correlation between the triglyceride glucose-body mass index (TyG-BMI ) and CVD as an assessment of insulin resistance (IR). However, it remains unknown whether this correlation exists in population with CKM syndrome. METHODS: All data for this study were obtained from the China Health and Retirement Longitudinal Study (CHARLS). The exposure was the participants' TyG-BMI at baseline, which was calculated using a combination of triglycerides (TG), fasting blood glucose (FBG) and body mass index (BMI). The primary outcome was CVD, which were determined by the use of a standardised questionnaire during follow-up. To examine the relationship between TyG-BMI and CVD incidence in population with CKM syndrome, both Cox regression analyses and restricted cubic spline (RCS) regression analyses were performed. RESULTS: A total of 7376 participants were included in the final analysis. Of these, 1139, 1515, 1839, and 2883 were in CKM syndrome stages 0, 1, 2, and 3, respectively, at baseline. The gender distribution was 52.62% female, and the mean age was 59.17 ± 9.28 (years). The results of the fully adjusted COX regression analyses indicated that there was a 6.5% increase in the risk of developing CVD for each 10-unit increase in TyG-BMI,95% confidence interval (CI):1.041-1.090. The RCS regression analyses demonstrated a positive linear association between TyG-BMI and the incidence of CVD in the CKM syndrome population (P for overall < 0.001, P for nonlinear = 0.355). CONCLUSIONS: This cohort study demonstrated a positive linear association between TyG-BMI index and increased CVD incidence in a population with CKM syndrome stage 0-3. This finding suggests that enhanced assessment of TyG-BMI index may provide a more convenient and effective tool for individuals at risk for CVD in CKM syndrome stage 0-3.

摘要

背景:美国心脏协会(AHA)最近提出了心血管-肾脏-代谢(CKM)综合征的概念,这是对代谢、肾脏和心血管疾病(CVD)相互作用日益重视的结果。此外,大量证据表明甘油三酯-葡萄糖-体重指数(TyG-BMI)与 CVD 之间存在相关性,可作为胰岛素抵抗(IR)的评估指标。然而,CKM 综合征患者中是否存在这种相关性尚不清楚。

方法:本研究所有数据均来自中国健康与养老追踪调查(CHARLS)。暴露因素为参与者基线时的 TyG-BMI,通过结合甘油三酯(TG)、空腹血糖(FBG)和体重指数(BMI)计算得出。主要结局为 CVD,通过随访期间使用标准化问卷确定。为了研究 CKM 综合征人群中 TyG-BMI 与 CVD 发生率之间的关系,同时进行了 Cox 回归分析和限制性立方样条(RCS)回归分析。

结果:共纳入 7376 名参与者进行最终分析。其中,1139、1515、1839 和 2883 名参与者在基线时分别处于 CKM 综合征 0、1、2 和 3 期。性别分布为 52.62%为女性,平均年龄为 59.17±9.28(岁)。完全调整后的 COX 回归分析结果表明,TyG-BMI 每增加 10 个单位,CVD 风险增加 6.5%,95%置信区间(CI)为 1.041-1.090。RCS 回归分析显示,在 CKM 综合征人群中,TyG-BMI 与 CVD 发生率之间存在正线性关联(整体 P<0.001,非线性 P=0.355)。

结论:本队列研究表明,CKM 综合征 0-3 期人群中 TyG-BMI 指数与 CVD 发生率增加呈正线性关联。这一发现表明,对 TyG-BMI 指数的强化评估可能为 CKM 综合征 0-3 期个体提供一种更方便、更有效的 CVD 风险评估工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/0462211725e4/12933_2024_2352_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/054bf240c70a/12933_2024_2352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/87e86a9c6573/12933_2024_2352_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/29feb4f5655d/12933_2024_2352_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/0462211725e4/12933_2024_2352_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/054bf240c70a/12933_2024_2352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/87e86a9c6573/12933_2024_2352_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/29feb4f5655d/12933_2024_2352_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dff/11308445/0462211725e4/12933_2024_2352_Fig4_HTML.jpg

相似文献

[1]
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2024-8-7

[2]
Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-2-28

[3]
Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0-3 and the development of a machine learning prediction model: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-4-16

[4]
Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study.

Cardiovasc Diabetol. 2025-2-28

[5]
Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China.

Cardiovasc Diabetol. 2024-1-6

[6]
Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-1-18

[7]
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-1-24

[8]
Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation.

Cardiovasc Diabetol. 2025-3-10

[9]
Insights into the complex relationship between triglyceride glucose-waist height ratio index, mean arterial pressure, and cardiovascular disease: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-2-28

[10]
The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies.

Cardiovasc Diabetol. 2025-3-24

引用本文的文献

[1]
Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review.

Mol Cell Biochem. 2025-9-10

[2]
Comparison of triglyceride-glucose index and triglyceride-glucose related indexes in predicting cardiovascular disease incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Front Endocrinol (Lausanne). 2025-8-22

[3]
Periodontitis, accelerated biological aging, and advanced stages in cardiovascular-kidney-metabolic syndrome in U.S. Adults: A mediation analysis.

Diabetes Res Clin Pract. 2025-8-25

[4]
Association Between Serum Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A 3-Year Longitudinal Cohort Study (2019-2022).

J Diabetes. 2025-8

[5]
Intrinsic capacity and its change predict cardiovascular disease risk in early cardiovascular-kidney-metabolic syndrome: a nationwide cohort study.

Open Heart. 2025-8-18

[6]
Metabolomic profiling reveals interindividual metabolic variability and its association with cardiovascular-kidney-metabolic syndrome risk.

Cardiovasc Diabetol. 2025-8-1

[7]
Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals.

Cardiovasc Diabetol. 2025-8-1

[8]
Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide cohort study.

Diabetol Metab Syndr. 2025-7-29

[9]
Association between changes in the triglyceride glucose-body roundness Index and cardiovascular disease risk in middle-aged and elderly Chinese adults: a nationwide longitudinal study from 2011 to 2015.

Front Nutr. 2025-7-11

[10]
Influence of metabolism-related comorbidities and insulin resistance on new onset of chronic kidney disease in a health check-up population: a two-stage retrospective cohort study.

BMJ Open Diabetes Res Care. 2025-7-27

本文引用的文献

[1]
Clinical features of early-onset type 2 diabetes and its association with triglyceride glucose-body mass index: a cross-sectional study.

Front Endocrinol (Lausanne). 2024

[2]
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2024-2-24

[3]
Association of triglyceride glucose-body mass index and hemoglobin glycation index with heart failure prevalence in hypertensive populations: a study across different glucose metabolism status.

Lipids Health Dis. 2024-2-22

[4]
Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study.

Front Endocrinol (Lausanne). 2024

[5]
Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China.

Cardiovasc Diabetol. 2024-1-6

[6]
Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: A prospective cohort study.

J Clin Lipidol. 2024

[7]
Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study.

Front Endocrinol (Lausanne). 2023

[8]
Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study.

Cardiovasc Diabetol. 2023-11-28

[9]
Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study.

Cardiovasc Diabetol. 2023-11-9

[10]
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.

JAMA. 2023-12-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索